Anda belum login :: 16 Apr 2025 10:39 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis
Oleh:
Shen, Qi
;
Hua, Ying
;
Wenxiao, Jiang
;
Zhang, Wenwen
;
Chen, Miaomiao
Jenis:
Article from Journal - ilmiah internasional
Dalam koleksi:
Fertility and Sterility (keterangan: ada di ClinicalKey) vol. 100 no. 06 (Dec. 2013)
,
page 1722-1726.
Topik:
Mifepristone
;
leiomyoma
;
meta-analysis
Ketersediaan
Perpustakaan FK
Nomor Panggil:
F02.K.2013.02
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Objective To conduct a meta-analysis of the studies assessing the effects of mifepristone on the uterus, uterine leiomyoma, and leiomyoma-related symptoms in premenopausal women. Design Meta-analysis. Setting Centers for reproductive care. Patient(s) Premenopausal women who suffered from leiomyoma. Intervention(s) We identified all of the studies published before December 2012 that compared the status of patients with leiomyoma before and after treatment with mifepristone. Main Outcome Measure(s) Leiomyoma-related symptoms, uterine or leiomyoma volume, changes in endometrial thickness. Result(s) A meta-analytic technique was used to study 11 randomized controlled trials involving 780 women with symptomatic uterine leiomyomas. The subjects received 2.5–25 mg/d of mifepristone for 3–6 months. Mifepristone could effectively reduce uterine and leiomyoma volume and alleviate leiomyoma symptoms, including hypermenorrhea, the mean menstrual blood loss, pelvic pain, pelvic pressure, anemia, and dysmenorrhea. There was no significant difference in the rate of atypical endometrial hyperplasia between the mifepristone treatment group and the placebo group. Conclusion(s) Mifepristone significantly reduced uterine and leiomyoma volume and alleviated leiomyoma-related symptoms. We recommend 2.5 mg of mifepristone administered daily for 3 or 6 months as the optimum clinical treatment for leiomyoma. There is insufficient evidence that mifepristone treatment led to atypical endometrial hyperplasia.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0 second(s)